覆盖未来型肝炎疫苗的挑战:审查和潜在的解决方案
Keshav Gandhi1, Yash Vijay1, Kimberly Page2
1Department of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, 851 S. Morgan St., Chicago, IL 60607, United States; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, 2160 S. First Ave., Maywood, IL 60153, United States; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, 1603 W. Taylor St., Chicago, IL 60612, United States.
Vaccine
|May 24, 2025
概括
型肝炎病毒 (HCV) 疫苗可以帮助到2030年消除HCV. 本综述确定了针对HCV疫苗接种的挑战和建议,特别是在注射药物的人群 (PWID) 中.
科学领域:
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
- 传染病流行病学 传染病流行病学
背景情况:
- 在全球范围内,C型肝炎病毒 (HCV) 造成的死亡率负担很大.
- 针对COVID-19和RSV的快速疫苗开发为迅速推出HCV疫苗提供了一个模型.
- 由于疫苗犹和注射毒品 (PWID) 的人群中高发病率,HCV疫苗的接受受到挑战.
研究的目的:
- 为了确定对HCV疫苗接种的潜在挑战.
- 为公共和社区卫生专业人员提供建议,以提高HCV疫苗的接受度.
- 支持世界卫生组织到2030年消除HCV的目标.
主要方法:
- 从PubMed. 的相关文献的综合叙事审查.
- 关于疫苗接受障碍的研究调查 (例如,COVID-19,乙型肝炎).
- 对HCV管理障碍的分析,特别是在PWID中.
主要成果:
- 确定了六个主要挑战:PWID的结构/社会障碍,疫苗安全/有效性问题,多剂量消耗,错误信息,对感染的认识/态度以及信息框架.
- 提出了四项建议:有针对性的教育活动,社区层面的支持计划,泛基因型/多价值/组合疫苗以及成本效益分析.
结论:
- 解决HCV疫苗接种中的潜在缺口需要多方面的策略.
- 建议包括将疫苗接种与减少危害的服务 (如注射器交换计划) 整合在一起.
- 疫苗接种计划的经济分析对于成功推广和消除HCV至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
384
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
384
Cancer Vaccines
523
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523


